EU regulator to probe ethical standards of Sputnik vaccine trials - FT

A dose of Russia's Sputnik V coronavirus disease (COVID-19) vaccine is prepared at a sport centre, as the country starts mass inoculation campaign with the Russian vaccine donated by Serbia, in Skopje, North Macedonia April 5, 2021. REUTERS/Ognen Teofilovski

(Reuters) - The EU drug regulator will begin investigations next week on whether clinical trials of Russia's Sputnik V COVID-19 vaccine followed global clinical and scientific guidelines, the Financial Times reported on Wednesday.

The European Medicines Agency's probe comes as people familiar with the regulator's approval process told the FT that Sputnik V trials had not been ethically run.